RATIONALE: PROTECT DC examines whether stroke navigators can improve cardiovascular risk factors in urban underserved individuals newly hospitalized for stroke or ischemic attack. Within one-year of hospital discharge, up to one-third of patients no longer adhere to secondary prevention behaviors. Adherence rates are lower in minority-underserved groups, contributing to health disparities. In-hospital programs increase use of stroke prevention therapies but may not be as successful in underserved individuals. In these groups, low literacy, limited healthcare access, and sparse community resources may reduce adherence. Lay community health workers (navigators) improve adherence in other illnesses through education and assisting in overcoming barriers to achieving desired health behaviors and obtaining needed healthcare services. AIMS AND DESIGN: PROTECT DC is a Phase II, single-blind, randomized, controlled trial comparing in-hospital education plus stroke navigators to usual care. Atherogenic ischemic stroke and transient ischemic attack survivors are recruited from Washington, DC hospitals. Navigators meet with participants during the index hospitalization, perform home visits, and meet by phone. They focus on stroke education, medication compliance, and overcoming practical barriers to adherence. The interventions are driven by the theories of reasoned action and planned behavior. STUDY OUTCOMES: The primary dependent measure is a summary score of four objective measures of stroke risk factor control: systolic blood pressure, low-density lipoprotein, hemoglobin Hb A1C, and antiplatelet agent pill counts. Secondary outcomes include stroke knowledge, exercise, dietary modification, and smoking cessation. CONCLUSION: PROTECT DC will determine whether a Phase III trial of stroke navigation for urban underserved individuals to improve adherence to secondary stroke prevention behaviors is warranted.
RCT Entities:
RATIONALE: PROTECT DC examines whether stroke navigators can improve cardiovascular risk factors in urban underserved individuals newly hospitalized for stroke or ischemic attack. Within one-year of hospital discharge, up to one-third of patients no longer adhere to secondary prevention behaviors. Adherence rates are lower in minority-underserved groups, contributing to health disparities. In-hospital programs increase use of stroke prevention therapies but may not be as successful in underserved individuals. In these groups, low literacy, limited healthcare access, and sparse community resources may reduce adherence. Lay community health workers (navigators) improve adherence in other illnesses through education and assisting in overcoming barriers to achieving desired health behaviors and obtaining needed healthcare services. AIMS AND DESIGN: PROTECT DC is a Phase II, single-blind, randomized, controlled trial comparing in-hospital education plus stroke navigators to usual care. Atherogenic ischemic stroke and transient ischemic attack survivors are recruited from Washington, DC hospitals. Navigators meet with participants during the index hospitalization, perform home visits, and meet by phone. They focus on stroke education, medication compliance, and overcoming practical barriers to adherence. The interventions are driven by the theories of reasoned action and planned behavior. STUDY OUTCOMES: The primary dependent measure is a summary score of four objective measures of stroke risk factor control: systolic blood pressure, low-density lipoprotein, hemoglobin Hb A1C, and antiplatelet agent pill counts. Secondary outcomes include stroke knowledge, exercise, dietary modification, and smoking cessation. CONCLUSION: PROTECT DC will determine whether a Phase III trial of stroke navigation for urban underserved individuals to improve adherence to secondary stroke prevention behaviors is warranted.
Authors: R L Sacco; B Boden-Albala; R Gan; X Chen; D E Kargman; S Shea; M C Paik; W A Hauser Journal: Am J Epidemiol Date: 1998-02-01 Impact factor: 4.897
Authors: B Ovbiagele; J L Saver; A Fredieu; S Suzuki; N McNair; A Dandekar; T Razinia; C S Kidwell Journal: Neurology Date: 2004-10-12 Impact factor: 9.910
Authors: Kyle R Allen; Susan Hazelett; David Jarjoura; Glenda C Wickstrom; K Hua; J Weinhardt; K Wright Journal: J Stroke Cerebrovasc Dis Date: 2002 Mar-Apr Impact factor: 2.136
Authors: Alexander T Schneider; Arthur M Pancioli; Jane C Khoury; Eric Rademacher; Alfred Tuchfarber; Rosemary Miller; Daniel Woo; Brett Kissela; Joseph P Broderick Journal: JAMA Date: 2003-01-15 Impact factor: 56.272
Authors: Martha Sajatovic; Curtis Tatsuoka; Elisabeth Welter; Kari Colon-Zimmermann; Carol Blixen; Adam T Perzynski; Shelly Amato; Jamie Cage; Johnny Sams; Shirley M Moore; Svetlana Pundik; Sophia Sundararajan; Charles Modlin; Cathy Sila Journal: Am J Health Promot Date: 2017-03-06
Authors: J Jaime Miranda; Miguel G Moscoso; Lijing L Yan; Francisco Diez-Canseco; Germán Málaga; Hector H Garcia; Bruce Ovbiagele Journal: J Neurol Sci Date: 2017-02-15 Impact factor: 3.181
Authors: Bernadeta Bridgwood; Kate E Lager; Amit K Mistri; Kamlesh Khunti; Andrew D Wilson; Priya Modi Journal: Cochrane Database Syst Rev Date: 2018-05-07
Authors: Anna De Simoni; Wendy Hardeman; Jonathan Mant; Andrew J Farmer; Ann Louise Kinmonth Journal: J Am Heart Assoc Date: 2013-08-20 Impact factor: 5.501